Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
7.46
13.11
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Hunan Fangsheng Pharmaceutical Co Ltd
Common Stock
Hunan Fangsheng Pharmaceutical Co Ltd
Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
|
Common Stock
ÂĄ439.1m
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
18%
|
||
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Common Stock
ÂĄ52k
|
CAGR 3-Years
0%
|
CAGR 5-Years
120%
|
CAGR 10-Years
N/A
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Common Stock
ÂĄ603.3m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
14%
|
||
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Common Stock
ÂĄ6.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
8%
|
CAGR 10-Years
16%
|
||
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Common Stock
ÂĄ1.8B
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
||
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Common Stock
ÂĄ401m
|
CAGR 3-Years
4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Hunan Fangsheng Pharmaceutical Co Ltd
Glance View
Hunan Fangsheng Pharmaceutical Co., Ltd. engages in the manufacture, distribution, research and development of pharmaceutical products. The company is headquartered in Changsha, Hunan and currently employs 2,808 full-time employees. The company went IPO on 2014-12-05. The firm's main products include Xuesaitong Dispersible Tablets, Xuesaitong Tablets, Tenghuang Jiangu Tablets, Dieda Huoxue Capsules, Lysine Dimension B12 Granules, Cefixoxime Tablets and Jinying Capsules. The firm distributes its products primarily in domestic market.
See Also
What is Hunan Fangsheng Pharmaceutical Co Ltd's Common Stock?
Common Stock
439.1m
CNY
Based on the financial report for Sep 30, 2024, Hunan Fangsheng Pharmaceutical Co Ltd's Common Stock amounts to 439.1m CNY.
What is Hunan Fangsheng Pharmaceutical Co Ltd's Common Stock growth rate?
Common Stock CAGR 10Y
18%
Over the last year, the Common Stock growth was 0%. The average annual Common Stock growth rates for Hunan Fangsheng Pharmaceutical Co Ltd have been 1% over the past three years , and 18% over the past ten years .